Literature DB >> 7900076

Construction and characterization of thrombin-resistant variants of recombinant human protein S.

G T Chang1, L Aaldering, T M Hackeng, P H Reitsma, R M Bertina, B N Bouma.   

Abstract

Protein S is a vitamin K-dependent plasma protein that functions as a cofactor of activated protein C (APC) in the inactivation of coagulation factors Va and VIIIa. Protein S, migrates as a doublet on reduced SDS polyacrylamide gel electrophoresis. This heterogeneity in molecular weight has been explained by limited proteolysis of protein S. Human protein S contains at Arg-49, Arg-60 and Arg-70 three potential cleavage sites. Whether cleavage occurs at all three sites is not known. To study the role of these arginine residues in human protein S, we have replaced them by leucine or isoleucine. All seven possible variants were constructed: three variants with single mutations (R49L, R60L, R70I), three variants with double mutations (R49L/R60L, R60L/R70I, R49L/R70I) and one variant with a triple mutation (R49L/R60L/R70I). On reduced SDS polyacrylamide gels the single and double variants migrate as a doublet just like the wild type protein S. The triple variant migrates as a single band at a molecular weight corresponding to the upper band of the doublet. The upper band of the single and double variants but not of the triple variant could be converted into the lower band by thrombin treatment. All variants showed cofactor activity to APC in a clotting assay. After thrombin treatment, this cofactor activity was abolished for the single (R49L, R60L, R70I) and double variants (R49L/R60L, R60L/R70I, R49L/R70I), while the triple variant (R49L/R60L/R70I) tested at several concentrations, retained its cofactor activity completely, suggesting resistance to thrombin. This shows that thrombin can cleave at all three arginine sites and that cleavage at each of these sites results in the loss of APC cofactor activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7900076

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  The Journey of Protein S from an Anticoagulant to a Signaling Molecule.

Authors:  V S Pilli; William Plautz; Rinku Majumder
Journal:  JSM Biochem Mol Biol       Date:  2016-08-08

Review 2.  Protein C anticoagulant and cytoprotective pathways.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

3.  A theoretical model for the Gla-TSR-EGF-1 region of the anticoagulant cofactor protein S: from biostructural pathology to species-specific cofactor activity.

Authors:  B O Villoutreix; O Teleman; B Dahlbäck
Journal:  J Comput Aided Mol Des       Date:  1997-05       Impact factor: 3.686

4.  Evidence for a protein S receptor(s) on human vascular smooth muscle cells. Analysis of the binding characteristics and mitogenic properties of protein S on human vascular smooth muscle cells.

Authors:  O Benzakour; C Formstone; S Rahman; C Kanthou; U Dennehy; M F Scully; V V Kakkar; D N Cooper
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

5.  Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain.

Authors:  Helena M Andersson; Márcia J Arantes; James T B Crawley; Brenda M Luken; Sinh Tran; Björn Dahlbäck; David A Lane; Suely M Rezende
Journal:  Blood       Date:  2010-03-22       Impact factor: 22.113

6.  The extended cleavage specificity of human thrombin.

Authors:  Maike Gallwitz; Mattias Enoksson; Michael Thorpe; Lars Hellman
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.